Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trialsPaul Guedeney, Roxana Mehran, Gennaro Giustino et al.|European Heart Journal|2019Cited by 203
Indirect comparison of the efficacy and safety of alirocumab and evolocumab: a systematic review and network meta-analysisPaul Guedeney, Gilles Montalescot, Sabato Sorrentino et al.|European Heart Journal - Cardiovascular Pharmacotherapy|2020Cited by 61
P5367Indirect comparison of the safety and efficacy of alirocumab and evolocumab: from a comprehensive meta-analysis of 30 randomized controlled trialsPaul Guedeney, Gilles Montalescot, Céline Chapelle et al.|European Heart Journal|2019Cited by 31
Determinants of Significant Out-Of-Hospital Bleeding in Patients Undergoing Percutaneous Coronary InterventionSabato Sorrentino, Roxana Mehran, Usman Baber et al.|Thrombosis and Haemostasis|2018Cited by 23
Efficacy and safety of P2Y12 inhibitor monotherapy after complex PCI: a collaborative systematic review and meta-analysisJohny Nicolas, Roxana Mehran, George Dangas et al.|European Heart Journal - Cardiovascular Pharmacotherapy|2022Cited by 21